Last viewed: RUBY


Prices are updated after-hours



nasdaq:RUBY Rubius Therapeutics, Inc.

RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (0.0% 1m) (137.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.16% volume)
Earnings Calendar: 2023-05-09
Market Cap: $ 5,157,528

http://www.rubiustx.com
Sec Filling | Patents | 223 employees


(US) Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.

cancer   autoimmunity   t-cell   metabolic   ceiling  

add to watch list Paper trade email alert is off

Press-releases


TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
Published: 2024-02-06 (Crawled : 12:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.08% H: 7.31% C: 5.53%
ALRN | $4.785 -4.3% -4.49% 85K twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 2.58% C: -7.08%

therapeutics
COUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer
Published: 2023-07-19 (Crawled : 13:20) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.8% C: 0.48%
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: 7.98% H: 0.0% C: 0.0%
GBIO | $2.81 1.08% 1.07% 250K twitter stocktwits trandingview |
Health Technology
| | O: -0.19% H: 9.21% C: -1.73%

pharmaceuticals
Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel
Published: 2023-02-28 (Crawled : 14:00) - globenewswire.com
AKYA | $3.81 -1.04% -1.05% 170K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.0% H: 0.27% C: -5.41%
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: 0.23% H: 14.07% C: 10.95%
PRGS | News S | $50.39 0.4% 0.38% 470K twitter stocktwits trandingview |
Technology Services
| | O: -0.61% H: 0.8% C: 0.44%


Cellarity Announces Close of $121 Million Series C Financing
Published: 2022-10-04 (Crawled : 12:00) - biospace.com/
OMGA | $2.4 -0.83% -0.83% 400K twitter stocktwits trandingview |
| | O: 0.0% H: 9.59% C: 6.97%
SANA | $7.605 -1.62% -1.64% 3.4M twitter stocktwits trandingview |
| | O: 3.0% H: 4.68% C: 4.36%
MCRB | $0.5671 -2.93% -3.02% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 2.1% H: 2.85% C: 2.69%
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 7.34% C: 6.96%
MRNA S | $101.44 -0.55% -0.55% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 2.22% H: 2.22% C: 1.62%
FHTX | $5.335 -3.53% -3.66% 120K twitter stocktwits trandingview |
Health Technology
| | O: 3.15% H: 7.96% C: 3.06%
EVLO | $0.3165 -87.39% 710K twitter stocktwits trandingview |
Health Technology
| | O: 0.95% H: 7.55% C: 6.6%
DNLI | $15.98 -3.74% -3.88% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 2.26% H: 2.33% C: 1.48%


Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference
Published: 2022-09-19 (Crawled : 14:00) - biospace.com/
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: 3.28% H: 0.0% C: -6.78%

conference therapeutics
Rubius Therapeutics to Provide Strategic Update
Published: 2022-09-12 (Crawled : 21:00) - globenewswire.com
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: -20.56% H: 14.12% C: 9.06%

therapeutics update
Cellarity Releases Novel, Open-Source, Single-Cell Dataset and Invites the Machine Learning and Computational Biology Communities to Develop New Algorithms Capable of Learning Fundamental Rules of Cell Behavior
Published: 2022-08-17 (Crawled : 13:20) - biospace.com/
OMGA | $2.4 -0.83% -0.83% 400K twitter stocktwits trandingview |
| | O: -3.81% H: 6.17% C: 0.44%
SANA | $7.605 -1.62% -1.64% 3.4M twitter stocktwits trandingview |
| | O: -1.77% H: 2.83% C: -2.57%
MCRB | $0.5671 -2.93% -3.02% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.79% H: 2.55% C: -1.09%
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 3.24% C: -4.97%
MRNA S | $101.44 -0.55% -0.55% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.74% H: 1.56% C: -4.27%
FHTX | $5.335 -3.53% -3.66% 120K twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 3.89% C: 1.79%
EVLO | $0.3165 -87.39% 710K twitter stocktwits trandingview |
Health Technology
| | O: -1.52% H: 4.61% C: 0.0%
DNLI | $15.98 -3.74% -3.88% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.99% H: 1.2% C: -1.9%

computational
Senda Biosciences Announces Close of $123 Million Series C Financing
Published: 2022-08-16 (Crawled : 12:00) - biospace.com/
OMGA | $2.4 -0.83% -0.83% 400K twitter stocktwits trandingview |
| | O: -2.4% H: 3.28% C: -3.28%
SANA | $7.605 -1.62% -1.64% 3.4M twitter stocktwits trandingview |
| | O: -0.12% H: 0.47% C: -6.05%
MCRB | $0.5671 -2.93% -3.02% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.58% H: 0.89% C: -0.18%
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: -0.19% H: 1.89% C: -2.77%
MRNA S | $101.44 -0.55% -0.55% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.44% H: 2.35% C: -4.57%
FHTX | $5.335 -3.53% -3.66% 120K twitter stocktwits trandingview |
Health Technology
| | O: -2.86% H: 4.55% C: 0.37%
EVLO | $0.3165 -87.39% 710K twitter stocktwits trandingview |
Health Technology
| | O: 1.09% H: 0.0% C: -5.04%
DNLI | $15.98 -3.74% -3.88% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.08% C: -3.34%


Rubius Therapeutics to Announce Second Quarter 2022 Financial Results
Published: 2022-07-26 (Crawled : 17:00) - biospace.com/
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.71% C: -4.11%

therapeutics results
HotSpot Therapeutics Appoints Jose Carmona to Board of Directors
Published: 2022-07-19 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 3.55% H: 0.0% C: -0.01%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 4.22% H: 0.26% C: -0.22%
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: 2.44% H: 0.55% C: -3.57%

therapeutics
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M twitter stocktwits trandingview |
n/a
| 23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M twitter stocktwits trandingview |
Finance
| 22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K twitter stocktwits trandingview |
Health Technology
| 22:30
BCDA P 2750 | $0.377 -1.4% 97K twitter stocktwits trandingview |
Health Technology
| 22:00
RMCF | $3.67 3.38% 3.27% 11K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar